ALNYLAM PHARMACEUTICALS, INC. : RAYMOND JAMES CUTS TO OUTPERFORM FROM STRONG BUY; CUTS TARGET PRICE TO $315 FROM $420

Reuters · 2d ago

Please log in to view news